XSTOZICC
Market cap2mUSD
Dec 23, Last price
0.47SEK
1D
21.93%
1Q
-86.66%
IPO
-98.42%
Name
Ziccum AB
Chart & Performance
Profile
Ziccum AB (publ) develops dry powder preparations of biological pharmaceuticals. It develops and commercializes LaminarPace, a spray drying technology that dries chemicals, vaccines, biologics, and drug substances at room temperature. The company was founded in 2017 and is headquartered in Lund, Sweden.
Valuation
Title SEK in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY |
---|---|---|---|---|---|---|---|
2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | |
Income | |||||||
Revenues | 3,747 21,941.18% | 17 240.00% | 5 0.00% | ||||
Cost of revenue | 27,033 | 1,373 | 22,464 | ||||
Unusual Expense (Income) | |||||||
NOPBT | (23,286) | (1,356) | (22,459) | ||||
NOPBT Margin | |||||||
Operating Taxes | (334) | 20 | |||||
Tax Rate | |||||||
NOPAT | (23,286) | (1,022) | (22,479) | ||||
Net income | (21,412) -24.75% | (28,454) 34.50% | (21,156) 21.99% | ||||
Dividends | |||||||
Dividend yield | |||||||
Proceeds from repurchase of equity | 27,967 | 2,413 | |||||
BB yield | |||||||
Debt | |||||||
Debt current | 571 | 571 | 571 | ||||
Long-term debt | 286 | 857 | 1,429 | ||||
Deferred revenue | |||||||
Other long-term liabilities | (857) | (1,429) | |||||
Net debt | (2,137) | (21,523) | (10,273) | ||||
Cash flow | |||||||
Cash from operating activities | (19,821) | (13,391) | (16,102) | ||||
CAPEX | (136) | (3,898) | (6,424) | ||||
Cash from investing activities | (136) | (3,898) | (6,424) | ||||
Cash from financing activities | 27,967 | 1,179 | |||||
FCF | (22,460) | 510 | (28,269) | ||||
Balance | |||||||
Cash | 2,994 | 22,951 | 12,273 | ||||
Long term investments | |||||||
Excess cash | 2,807 | 22,950 | 12,273 | ||||
Stockholders' equity | (96,816) | (76,099) | (48,169) | ||||
Invested Capital | 106,257 | 106,139 | 79,448 | ||||
ROIC | |||||||
ROCE | |||||||
EV | |||||||
Common stock shares outstanding | 13,873 | 13,865 | 11,053 | ||||
Price | |||||||
Market cap | |||||||
EV | |||||||
EBITDA | (22,068) | 4,053 | (21,617) | ||||
EV/EBITDA | |||||||
Interest | 167 | 20 | |||||
Interest/NOPBT |